1 이상혁, "노년기 우울증과 스트레스" 대한스트레스학회 15 (15): 295-301, 2007
2 Rush AJ, "xDexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression" 41 : 915-928, 1997
3 Chaudron LH, "relationship between postpartum psychosis and bipolar disorder: a review" 64 : 1284-1292, 2003
4 Weissman MM, "Wickramaratne P, Prusoff BA. Early-onset major depression in patients and their children" 15 : 269-277, 1988
5 Sohn CH, "Update on the biology of seasonal affective disorder" 10 : 635-646, 2005
6 Rush AJ, "The varied clinical presentations of major depressive disorder" 8 : 4-10, 2007
7 Thase ME, "The role of Axis II comorbidity in the management of patients with treatment-resistant depression" 19 : 287-309, 1996
8 Lee SH, "The relationship between treatment response with clinical variables in major depressive disorder" 199-, 2006
9 Wilhelm K, "The relationship between interpersonal sensitivity, anxiety disorders and major depression" 79 : 33-41, 2004
10 Gomez RG, "The neuropsychological profile of psychotic major depression and its relation to cortisol" 60 : 472-478, 2006
1 이상혁, "노년기 우울증과 스트레스" 대한스트레스학회 15 (15): 295-301, 2007
2 Rush AJ, "xDexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression" 41 : 915-928, 1997
3 Chaudron LH, "relationship between postpartum psychosis and bipolar disorder: a review" 64 : 1284-1292, 2003
4 Weissman MM, "Wickramaratne P, Prusoff BA. Early-onset major depression in patients and their children" 15 : 269-277, 1988
5 Sohn CH, "Update on the biology of seasonal affective disorder" 10 : 635-646, 2005
6 Rush AJ, "The varied clinical presentations of major depressive disorder" 8 : 4-10, 2007
7 Thase ME, "The role of Axis II comorbidity in the management of patients with treatment-resistant depression" 19 : 287-309, 1996
8 Lee SH, "The relationship between treatment response with clinical variables in major depressive disorder" 199-, 2006
9 Wilhelm K, "The relationship between interpersonal sensitivity, anxiety disorders and major depression" 79 : 33-41, 2004
10 Gomez RG, "The neuropsychological profile of psychotic major depression and its relation to cortisol" 60 : 472-478, 2006
11 Demyttenaere K, "The many faces of fatigue in major depressive disorder" 8 : 93-105, 2005
12 Leventhal AM, "The empirical status of melancholia: implications for psychology" 25-44, 2005
13 Golden RN, "The efficacy of light therapy in the treatment of mood disorder: a review and meta-analysis of the evidence" 162 : 656-662, 2005
14 Seok JH, "The conditional and characteristic factors of patients with major depressive disorder examined with clinical scales" 198-, 2006
15 Austin MP, "Targeted group antenatal prevention of postnatal depression: a review" 107 : 244-250, 2003
16 Kovacs M, "Suicidal behaviors and childhoodonset depressive disorders: a longitudinal investigation" 32 : 8-20, 1993
17 Kennedy SH, "Sexual dysfunction before antidepressant therapy in major depression" 56 : 201-208, 1999
18 Khan A, "Severity of depression and response to antidepressant and placebo: an analysis of the Food and Drug Administration database" 22 : 40-45, 2002
19 Bloch M, "Risk factors associated with the development of postpartum mood disorders" 88 : 9-18, 2005
20 Ramana R, "Remission and relapse in major depression: a two-year prospective follow-up study" 25 : 1161-1170, 1995
21 Thase ME, "Recognition and diagnosis of atypical depression" 68 (68): 11-16, 2007
22 Coryell W, "Psychotic depression" 57 (57): 27-31, 1996
23 Park SS, "Psychosocial risk factors of postpartum depression" 7 : 124-133, 1999
24 Ohayon MM, "Prevalence of depressive episodes with psychotic features in the general population" 159 : 1855-1861, 2002
25 Wijkstra J, "Pharmacological treatment for psychotic depression" 2005
26 Terman M, "On the question of mechanism in phototherapy for seasonal affective disorder: considerations of clinical efficacy and epidemiology" 3 : 155-172, 1988
27 Fleming SK, "Neuropsychological correlates of psychotic features in major depressive disorder: a review and meta-analysis" 38 : 27-35, 2004
28 Raison CL, "Neuropsychiatric adverse effects of interferon-alpha: recognition and management" 19 : 105-123, 2005
29 Porter RJ, "Neurocognitive impairment in drug-free patients with major depressive disorder" 182 : 214-220, 2003
30 Bartolini M, "Motivational symptoms of depression mask preclinical Alzheimer’s disease in elderly subjects" 19 : 31-36, 2005
31 Kessler RC, "Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication" 62 : 593-602, 2005
32 Breslau N, "Major depression and stages of smoking. A longitudinal investigation" 55 : 161-166, 1998
33 Boivin DB, "Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders" 25 : 446-458, 2000
34 Keller MB, "Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression" 44 : 348-360, 1998
35 Breslau N, "Headache and major depression: is the association specific to migraine?" 54 : 308-313, 2000
36 Drevets WC, "Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression" 126 : 413-431, 2000
37 Gilmer WS, "Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project" 112 : 425-433, 2005
38 Alexopoulos GS, "Executive dysfunction, heart disease burden, and remission of geriatric depression" 29 : 2278-2284, 2004
39 Kasper S, "Epidemiological findings of seasonal changes in mood and behavior. A telephone survey of Montgomery County, Maryland" 46 : 823-833, 1989
40 Rosenthal NE, "Effects of light treatment on core body temperature in seasonal affective disorder" 27 : 39-50, 1990
41 Russell JM, "Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression" 13 : 18-27, 2001
42 Björntorp P, "Do stress reactions cause abdominal obesity and comorbidities?" 2 : 73-86, 2001
43 Lyketsos CG, "Diagnosis and treatment of depression in Alzheimer’s disease. A practical update for the clinician" 17 : 55-64, 2004
44 Miller GE, "Depressive symptoms and the regulation of proinflammatory cytokine expression in patients with coronary heart disease" 59 : 231-236, 2005
45 Siris SG, "Depression in schizophrenia: perspective in the era of “Atypical” antipsychotic agents" 157 : 1379-1389, 2000
46 McWilliams LA, "Depression and anxiety associated with three pain conditions: results from a nationally representative sample" 111 : 77-83, 2004
47 Otte C, "Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The Heart and Soul Study" 56 : 241-247, 2004
48 American Psychiatric Association, "DSM-IV-TR Text Revision: Diagnostic and Statistical Manual for Mental Disorders, 4th ed" American Psychiatric Press 2000
49 Rush AJ, "DSM-IV mood disorders: final overview ; DSM-IV Sourcebook, vol 4" American Psychiatric Press 1019-1033, 1998
50 Dannon PN, "Current and emerging somatic treatment strategies in psychotic major depression" 6 : 73-80, 2006
51 Overbeek T, "Comorbidity of obsessive- compulsive disorder and depression: prevalence, symptom severity, and treatment effect" 63 : 1106-1112, 2002
52 Kessler RC, "Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey" 30 : 17-30, 1996
53 Fineberg NA, "Comorbid depression in obsessive compulsive disorder (OCD): symptomatic differences to major depressive disorder" 87 : 327-330, 2005
54 Bosboom JL, "Cognitive dysfunction and dementia in Parkinson's disease" 111 : 1303-1315, 2004
55 Brady KT, "Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress" 162 : 1483-1493, 2005
56 Fava M, "Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder" 34 : 1299-1308, 2004
57 Sarter M, "Choline transporters, cholinergic transmission and cognition" 6 : 48-56, 2005
58 Mayeux R, "Behavioral manifestations of movement disorders. Parkinson’s and Huntington’s disease" 2 : 527-540, 1984
59 Capuron L, "Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy" 18 : 205-213, 2004
60 Onder G, "Association between pain and depression among older adults in Europe: results from the Aged in Home Care (AdHOC) project: a cross-sectional study" 66 : 982-988, 2005
61 Egeland J, "Asbjornsen A, Lund A, et al. Attention profile in schizophrenia compared with depression: differential effects of processing speed, selective attention and vigilance" 108 : 275-284, 2003
62 Whitehead C, "Antidepressants for the treatment of depression in people with schizophrenia: a systematic review" 33 : 589-599, 2003
63 Montgomery SA, "Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction" 69 : 119-140, 2002
64 Klein DN, "A family study of major depressive disorder in a community sample of adolescents" 58 : 13-20, 2001